Hyperfine, Inc. (HYPR): Projected Sales Volume

Hyperfine, Inc. (HYPR) maintains an innovative status with its portable Swoop MRI, triggering market volatility that this chart on GURU.Markets reflects through a projected product realization metric. The 0.02 level captures fresh values as the company expands its installed base to stabilize revenue and integrates software with AI platforms to organically grow its clinical footprint.

HYPR - Hyperfine Medical Company Revenue Forecast over the range 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for Hyperfine Inc (HYPR)

- stock value and consensus price forecast:

Price Chart Hyperfine, Inc.|HYPR - Consensus Target

- stock exchange capitalization data:

Market Capitalization Hyperfine Inc|HYPR - Total Enterprise Value

- book capitalization information:

Book Value per Share Hyperfine|HYPR - Accounting Capitalization|Market Capitalization to Book Value Ratio hyperfine.io|HYPR - Company Total Asset Base

- debt level and financial liquidity data:

- earnings and market ratios statistics:

HYPR - Company Net Income|Expected Profit Hyperfine, Inc.|HYPR - Market Cap to Net Income Ratio|Projected Price to Earnings Hyperfine|HYPR - PEG Multiple|EV/EBITDA Multiple Hyperfine Inc|HYPR - Operating income before deduction of amortization|Earnings per share for the last twelve months Hyperfine|HYPR - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months hyperfine.io|HYPR - Net earnings per share growth this year|Earnings growth forecast for next year Hyperfine, Inc.

- sales revenue and business income indicators:

HYPR - Company Total Revenue|Company Projected Revenue Hyperfine, Inc.|HYPR - Market Cap to Revenue Ratio|Forward Price-to-Revenue Multiple Hyperfine Inc

Comprehensive company analysis:HYPR Hyperfine, Inc.

The calculation model for this metric assesses revenue potential through the lens of operational efficiency, determining the business's ability to generate cash flow amidst market volatility. This sales volume projection for Hyperfine, Inc. (HYPR) measures the resilience of demand for portable MRI systems equipped with AI algorithms, allowing investors to evaluate the scaling pace of innovations and avoid entering the asset at a local peak.

Competing companies

Company Projected Revenue Abbott Laboratories (ABT)|Company Future Sales Volume thermofisher.com TMO|Projected Sales Volume GEHC (GE HealthCare Technologies)|Mettler-Toledo (MTD) - Company Expected Sales Volume|Waters Corp. - Projected Sales Volume|TECH (Bio-Techne Inc.) - Company Revenue Forecast|BRKR: Projected Sales Volume|AZTA - Company Future Sales|VREX (Varex Imaging Corporation) - Projected Sales Volume|Company Future Sales Volume Semler Scientific Inc (SMLR)|Projected Sales Volume BFLY|Projected Sales Volume Mesa Laboratories Corp. (MLAB)|Company Projected Revenue Quantum-Si QSI|nanox.vision - Company Projected Revenue|QTRX: Company Future Sales Volume|Company Future Revenue MASS (908 Devices Inc)|CV: Projected Sales Volume|Company Expected Sales Volume MaxCyte Inc (MXCT)|Company Projected Revenue Rapid Micro Biosystems Inc.|SEER - Company Sales Forecast|Company Future Sales Volume FONR (FONAR)|Projected Sales Volume daxor.com (DXR)|Projected Sales Volume MDAI (Spectral AI, Inc.)|Company Future Sales Organovo Holdings, Inc. (VIVS)|ACON - Company Projected Revenue|Company Expected Revenue AKYA|ThermoGenesis Holdings (THMO) - Company Projected Revenue|Company Future Sales Volume Talis Biomedical Corporation|TTOO (T2 Biosystems, Inc) - Projected Sales Volume